drugset / Trial / NCT02183714

The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances

NCT02183714

Phase 3 Completed 146 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effect of Songha Night ® on insomnia, anxiety and quality of life compared to placebo in patients with mild to moderate insomnia.

Timeline

Start
1998-05
Primary completion
1998-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Songha® Night Unknown